Recognised among the world's top 250 hospitals for 2024 and ranked within the top 75 globally for its outstanding contributions in Neurology, Cardiology, and Oncology by the prestigious Newsweek SMC continues to set the standard for exceptional patient care. Accredited by the Australian Council on Healthcare Standards, its commitment to excellence is unwavering, ensuring patients receive the highest quality of care and support.
This collaboration underscores SMC's commitment to providing the highest standard of care and embracing innovative technologies to drive positive change in healthcare delivery. The deployment of Annalise.ai's solution at SMC marks a significant milestone in the hospital's journey towards revolutionising patient care and enhancing healthcare outcomes.
The partnership between SMC and Annalise.ai reflects a shared vision of leveraging AI technology to transform healthcare delivery and improve patient outcomes. With this collaboration, SMC aims to set new benchmarks in healthcare excellence and inspire positive change in the industry.
About the Sunway Medical Centre, Sunway City:
Sunway Medical Centre is the largest private quaternary hospital in Malaysia with 724 licensed beds and is committed to becoming an international healthcare institution of choice. The hospital offers a comprehensive range of medical services, which include state-of-the-art facilities and advanced medical technologies for outpatient and inpatient speciality care, health and wellness programmes and 24-hour emergency services, which includes the newly opened dedicated Children’s Emergency, the first private hospital to offer this service. These are supported by a strong system comprising more than 3,500 dedicated healthcare and hospitality professionals.
Recognising the increasingly sophisticated needs in healthcare, SMC has developed niche areas of medical service, from the field of neurosciences to advanced cancer treatment, and from clinical research to bio-medical technology. Some of the core specialty areas include Oncology, Women and Children, Neuroscience, Heart and Lung, Bone and Joint, Robotic Surgery & MIS, and Digestive Health services. Its areas of expertise also include kidney transplant, bone marrow transplant, cochlear implant, and cornea transplant, as well as cell-based and gene-based therapies.
About Annalise.ai:
Annalise.ai is a global health-tech firm that has touched the lives of millions across the globe. Our patient-first approach is proudly clinician-led and comes from a deep understanding of the challenges faced in medical imaging. Our AI provides clinicians with a second set of eyes, allowing them to confidently review radiological studies and deliver better health outcomes for patients. With accelerating advances in medical imaging technology, radiologists and other healthcare providers are now expected to diagnose patients quickly and accurately. Annalise.ai fuses the highest quality imaging data with the very best in computer science to produce comprehensive AI clinical decision support solutions, empowering clinicians to make accurate decisions faster. Today, Annalise.ai is cleared to be used in 40+ countries.
Back to HCB News
